SCHEMBL22947657

SCHEMBL22947657

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc([Si]4(c5ccccc5)c5ccccc5-c5ccccc54)cc3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 3/20 0.42
MEN1 O00255 6/20 0.41
KMT2A Q03164 6/20 0.41
HPGD P15428 3/20 0.41
MAPT P10636 3/20 0.41
ALDH1A1 P00352 2/20 0.41
ADORA2A P29274 3/20 0.40
ADORA1 P30542 3/20 0.40
ADORA3 P0DMS8 2/20 0.40
ADORA2B P29275 2/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
POLB P06746 2/20 0.38
NTSR1 P30989 1/20 0.37
GPR55 Q9Y2T6 1/20 0.36
RAB9A P51151 5/20 0.36
NPC1 O15118 4/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 3/20 0.36
TP53 P04637 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15501800 0.98 L3MBTL1 (0.41) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL22947216 0.90 MEN1 (0.40) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL22947367 0.90 MEN1 (0.40) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL15501979 0.90 MEN1 (0.51) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL22572806 0.89 MEN1 (0.39) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL22572812 0.89 MEN1 (0.39) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL22949569 0.89 MEN1 (0.39) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL22947279 0.89 MEN1 (0.39) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL22949298 0.89 MEN1 (0.39) L3MBTL1MEN1KMT2AHPGDMAPT
SCHEMBL22947694 0.89 MEN1 (0.39) L3MBTL1MEN1KMT2AHPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210036245-A1 HETEROAROMATIC COMPOUNDS MERCK PATENT GMBH (DE) 2021-02-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210036245-A1 HETEROAROMATIC COMPOUNDS ETV6, FES, LEF1 L3MBTL1 3138/4885MEN1 2439/4885KMT2A 2115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.